Skip to search formSkip to main contentSkip to account menu

Helixor

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Background Up to 88% of oncological patients apply complementary therapies and up to 77% apply complementary mistletoe therapy in… 
2018
2018
Objective In the present observational study, the influence of internal coherence on shared decision-making for chemotherapy (CTX… 
2018
2018
PurposeManifestations of malignant pleural effusions (MPEs) are alleviated by local therapies as well as by systemic treatment… 
Review
2016
Review
2016
Background. Mistletoe therapy (MT) is widely used in patient-centered integrative cancer care. The objective of this study was to… 
2015
2015
Background. Intratumoral (IT) injection of European mistletoe (Viscum album L) preparations might induce local tumor response… 
2014
2014
Background. Breast cancer patients receiving adjuvant chemotherapy often experience a loss of quality of life. Moreover… 
2014
2014
Background. Traditional mistletoe therapy in cancer patients involves subcutaneous applications of Viscum album L. preparations… 
Review
2013
Review
2013
1990
1990
  • A. Kast, S. Hauser
  • Schweizerische Rundschau fur Medizin Praxis…
  • 1990
  • Corpus ID: 10580708
Helixor is an aqueous cold extract from fresh mistletoe, obtained from fir, pine and apple trees. A number of components with… 
1989
1989
Viscum album extracts (Helixor) were investigated for their potency to influence natural killer cell (NK) cytotoxicity of human…